APA (7th ed.) Citation

AN, R., PV, J., HJ, D., TD, C., JH, T., PA, A., . . . CJ, P. (2021). Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort. International journal of cardiology, 326, 131. https://doi.org/10.1016/j.ijcard.2020.10.043

Chicago Style (17th ed.) Citation

AN, Raval, et al. "Point of Care, Bone Marrow Mononuclear Cell Therapy in Ischemic Heart Failure Patients Personalized for Cell Potency: 12-month Feasibility Results from CardiAMP Heart Failure Roll-in Cohort." International Journal of Cardiology 326 (2021): 131. https://doi.org/10.1016/j.ijcard.2020.10.043.

MLA (9th ed.) Citation

AN, Raval, et al. "Point of Care, Bone Marrow Mononuclear Cell Therapy in Ischemic Heart Failure Patients Personalized for Cell Potency: 12-month Feasibility Results from CardiAMP Heart Failure Roll-in Cohort." International Journal of Cardiology, vol. 326, 2021, p. 131, https://doi.org/10.1016/j.ijcard.2020.10.043.